Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
CONCLUSION: N3-stage was an independent prognostic factor for LRF. Receiving a pretreatment PET scan and receiving PCI were prognostic factors for improved OS. Reduction in LRF may be achieved with dose-escalation in patients with N3-stage. This can be evaluated in prospective dose-escalation trials.
PMID: 26203924 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Winther-Larsen A, Hoffmann L, Moeller DS, Khalil AA, Knap MM Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | PET Scan | Small Cell Lung Cancer | Study | Toxicology